Cargando…
Treatment of Anemia in Kidney Disease: Beyond Erythropoietin
Anemia is common in patients with chronic kidney disease. Treatment with erythropoiesis-stimulating agents has decreased transfusion rates, but has not been consistently shown to improve cardiovascular outcomes or quality of life. Moreover, treatment to hemoglobin levels normal for the general popul...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484111/ https://www.ncbi.nlm.nih.gov/pubmed/34622095 http://dx.doi.org/10.1016/j.ekir.2021.05.028 |